Techcyte and EVIDENT Expand Partnership with Flexible Business Models for End-to-End Digital Pathology - The National Law Review

Techcyte and EVIDENT Expand Partnership with Flexible Business Models for End-to-End Digital Pathology

The National Law Review

Techcyte and EVIDENT have announced an expansion of their partnership, introducing flexible business models for end-to-end digital pathology solutions.